In a landmark move, the Food and Drug Administration (FDA) issued their inaugural draft guidance on the registration and listing of cosmetic product facilities and products on August 7, 2023. This is per the new obligations sanctioned under the Modernization of Cosmetics Regulation Act of 2022 (MoCRA).
Under this directive, it is now mandatory for cosmetic product manufacturers and processors to register their facilities with the FDA and renew these registrations biennially. Failure to comply with these requirements may result in serious legal ramifications, which could jeopardize their ability to operate within the remits of the United States.
This development marks a significant shift in the FDA’s approach to cosmetics regulation, with a heightened focus on consumer safety and transparency in the cosmetics industry. It is reflective of the broader changes ushered in by MoCRA, which seeks to modernize the way cosmetics are regulated and brought to market.
For further insight into this development, refer to the article by Akerman LLP.
Legal professionals around the globe, particularly those engaged in the cosmetics and personal care industry, should pay heed to this evolving landscape of regulatory requirements. It is advised to familiarize oneself with the specifics of the guidance and consider seeking expert legal counsel to ensure compliance.